1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Session

$Thumbnail for Solving the Sequencing Labyrinth: A Reinforcement Learning Meta-Analysis of Optimal Treatment Pathways in Triple-Class Refractory Multiple Myeloma$

MM - 1498

Solving the Sequencing Labyrinth: A Reinforcement Learning Meta-Analysis of Optimal Treatment Pathways in Triple-Class Refractory Multiple Myeloma

Haroon Alamy

Poster Presenter: Haroon Alamy

Thumbnail for Lymphoid-Biased Enrichment of Homologous Recombination Repair Gene Alterations in 22,954 Hematologic Malignancies from AACR Project GENIE v18.0: A Real-World Genomic Map to Prioritize PARP- and DDR-Directed Drug Development in Heme-Onc

CT - 1501

Lymphoid-Biased Enrichment of Homologous Recombination Repair Gene Alterations in 22,954 Hematologic Malignancies from AACR Project GENIE v18.0: A Real-World Genomic Map to Prioritize PARP- and DDR-Directed Drug Development in Heme-Onc

Nency Ganatra

Poster Presenter: Nency Ganatra

SOHO 2026 Annual Meeting

Posters by Session

Solving the Sequencing Labyrinth: A Reinforcement Learning Meta-Analysis of Optimal Treatment Pathways in Triple-Class Refractory Multiple Myeloma

Lymphoid-Biased Enrichment of Homologous Recombination Repair Gene Alterations in 22,954 Hematologic Malignancies from AACR Project GENIE v18.0: A Real-World Genomic Map to Prioritize PARP- and DDR-Directed Drug Development in Heme-Onc

Infectious Mortality in Hematologic Malignancies in the United States: A 25-Year Analysis of Pathogen-Specific Underlying Causes of Death Using CDC WONDER Data, 1999-2024

BTK Inhibitors Versus Venetoclax and Obinutuzumab in Anticoagulated Chronic Lymphocytic Leukemia Patients: A Propensity-Matched Analysis of Bleeding Outcomes

Infectious Complications and Antibiotic Utilization During the Expected Cytokine Release Syndrome Window After CAR T-Cell Therapy

Clinically Relevant Subgroup Analysis From the Randomized Phase 3 EPCORE FL-1 Trial: Treatment (Tx) Effect of Epcoritamab (E) With Lenalidomide and Rituximab (R2) in Relapsed/Refractory Follicular Lymphoma (R/R FL)

Molecular and Pathologic Staging Gaps in Mycosis Fungoides and Sιzary Syndrome: Real-World Evidence From the LEO-MER Prospective Cohort

Extramedullary Disease and Prolonged Hematotoxicity After Real-World Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A Transatlantic Evidence Synthesis

Age-, Sex-, Race-, and Ethnicity-Dependent Architecture of the AML DriverMutational Landscape: A Real-World Analysis of 5,111 Patients in AACRProject GENIE v18.0